|
Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs
|
19 September 2016 |
|
HIGHLY INCREASED 125I-JR11 ANTAGONIST BINDING IN VITRO REVEALS NOVEL INDICATIONS FOR SST2 TARGETING IN HUMAN CANCERS
|
13 September 2016 |
|
Melatonin, an inhibitory agent in breast cancer
|
13 September 2016 |
|
ATRA mechanically reprograms pancreatic stellate cells to suppress matrix remodelling and inhibit cancer cell invasion
|
09 September 2016 |
|
Quantitative proteomic profiling reveals that diverse metabolic pathways are influenced by melatonin in an in vivo model of ovarian carcinoma
|
09 September 2016 |
|
Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis
|
07 September 2016 |
|
Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer
|
07 September 2016 |
|
Association of shift-work, daytime napping, and nighttime sleep with cancer incidence and cancer-caused mortality in Dongfeng-tongji cohort study
|
02 September 2016 |
|
Discovery at the interface: Toward novel anti-proliferative agents targeting human estrogen receptor/S100 interactions
|
01 September 2016 |
|
Vitamin D and urological cancers
|
26 August 2016 |